| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.092 | 0.05 |